Hemogenyx Pharmaceuticals PLC Admission of Shares to Official List (2080P)
February 07 2023 - 9:30AM
UK Regulatory
TIDMHEMO
RNS Number : 2080P
Hemogenyx Pharmaceuticals PLC
07 February 2023
7 February 2023
Hemogenyx Pharmaceuticals plc
("Hemogenyx Pharmaceuticals" or the "Company")
Admission of Shares to Official List
Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces that it has
applied to the Financial Conduct Authority to admit 2 ordinary
shares of 1 pence each in the Company to the Official List in
relation to a historical transaction. It is expected that the
shares will be admitted on or around 8 February 2023. The total
issued share capital of the Company will remain 1,141,999,321
ordinary shares of 1 pence each, none of which are held in
treasury.
Enquiries:
Hemogenyx Pharmaceuticals plc https://hemogenyx.com
Dr Vladislav Sandler, Chief Executive
Officer & Co-Founder headquarters@hemogenyx.com
Peter Redmond, Director peter.redmond@hemogenyx.com
Tel: +44 (0)20 3470
SP Angel Corporate Finance LLP 0470
Matthew Johnson, Vadim Alexandre,
Adam Cowl
Tel: +44 (0)20 7469
Peterhouse Capital Limited 0930
Lucy Williams, Duncan Vasey, Charles
Goodfellow
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSZZGGZDNFGFZM
(END) Dow Jones Newswires
February 07, 2023 09:30 ET (14:30 GMT)
Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hemogenyx Pharmaceuticals (LSE:HEMO)
Historical Stock Chart
From Apr 2023 to Apr 2024